Skip to main content
Sequana Medical N.V. logo

Sequana Medical N.V. — Investor Relations & Filings

Ticker · SEQUA ISIN · BE0974340722 LEI · 8755009AN12Y4PEOII07 BR Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2025-04-22 Capital/Financing Update
Country BE Belgium
Listing BR SEQUA

About Sequana Medical N.V.

https://www.sequanamedical.com/

Sequana Medical N.V. is a commercial-stage medical device company focused on developing treatments for drug-resistant fluid overload, a frequent complication in patients with liver disease, heart failure, and cancer. The company's primary product is the alfapump®, a fully implanted, wirelessly charged system that automatically and continuously removes ascites (fluid accumulation in the abdomen) into the bladder for natural elimination. It is the first U.S. FDA-approved active implantable medical device for treating recurrent or refractory ascites due to liver cirrhosis, designed to reduce or eliminate the need for therapeutic paracentesis. Sequana Medical is also advancing its DSR® (Direct Sodium Removal) therapy platform, a novel approach for managing fluid overload in heart failure patients.

Recent filings

Filing Released Lang Actions
8 -- Special Board Report Authorised Capital (NL).pdf
Capital/Financing Update Classification · 95% confidence The document is titled "BIJZONDER VERSLAG VAN DE RAAD VAN BESTUUR OVEREENKOMSTIG ARTIKEL 7:199 VAN HET WETBOEK VAN VENNOOTSCHAPPEN EN VERENIGINGEN" (Special Report of the Board of Directors pursuant to Article 7:199 of the Companies and Associations Code). This report is being presented to the Extraordinary General Meeting of Shareholders regarding the proposal to renew the powers granted to the board of directors to increase the company's capital under the authorized capital framework. This document details the legal basis, past usage, and proposed renewal of capital increase authority, which directly relates to capital structure changes and shareholder voting on such matters. Since it is a detailed report presented for a shareholder meeting concerning capital structure, it strongly aligns with the 'Capital/Financing Update' (CAP) category, as it is a formal proposal/report about capital management powers. While it relates to a future shareholder meeting, the core content is the capital proposal itself, making CAP more specific than AGM-R or DEF 14A (which is remuneration focused). Given the focus on renewing authorization for capital increases, CAP is the most appropriate fit.
2025-04-22 Dutch
9 -- 2025 Share Option Plan Board Report (ENG).pdf
Management Reports Classification · 95% confidence The document is explicitly titled 'REPORT OF THE BOARD OF DIRECTORS IN ACCORDANCE WITH ARTICLES 7:180 AND 7:191 OF THE BELGIAN COMPANIES AND ASSOCIATIONS CODE'. This structure, detailing proposals for share options, justification for disapplying preferential subscription rights, and referencing specific articles of a national corporate code (Belgian Companies and Associations Code), strongly indicates a formal report prepared by the Board of Directors for a shareholder meeting (EGM). While it deals with share capital changes (which might suggest SHA), the primary function is a detailed justification report required by corporate law regarding a specific corporate action (issuance of options and disapplication of rights). This aligns best with a general corporate governance or management report, but given the context of being a formal report required by law for an upcoming shareholder meeting concerning capital structure changes, it is most closely related to the information provided to shareholders regarding management's proposals. Since there isn't a specific code for 'Board Report on Share Issuance Proposal', I must choose the closest fit. It is a detailed report, not a short announcement (RPA). It concerns management's proposal regarding capital structure/share rights. The closest fit among the provided options that covers detailed management/board reporting on corporate actions is often captured under general governance or management reports. However, the core subject is the proposal to issue shares/options and the associated capital structure change. Since it is a formal report detailing management's proposal for a capital change (share options), it is a comprehensive document. It is not a DEF 14A (Remuneration) or a simple DIV notice. Given the detailed nature and the focus on management's proposal regarding share issuance/rights, it functions as a detailed management report supporting a resolution for the EGM. If the EGM materials were present, DEF 14A might apply, but this is the Board's justification report. I will classify this as a Management Report (MDA) as it is the Board's detailed explanation supporting a corporate action, or potentially Governance Information (CGR). Since it is a formal report required by law detailing management's rationale for a capital action, MDA is a strong candidate, but CGR covers internal rules and board structure. Given the focus on the proposal and justification, MDA seems slightly better than CGR, but the document is highly specific to capital structure changes. Since the document details the proposal for share options and the justification for overriding shareholder rights, which is a key governance/management decision, I will lean towards MDA as it is the Board's detailed explanation of the proposed action and its rationale, which is a core component of management reporting. Revisiting the options: It is a formal report required by Belgian law regarding a proposal to issue share options and disapply pre-emption rights, to be voted on at an EGM. This is highly specific corporate action reporting. It is not an ER, IR, or 10-K. It is a formal report detailing management's plan. MDA (Management Reports) is defined as 'Management's detailed explanation of financial results, business trends, and outlook.' While this isn't strictly financial results, it is a detailed management explanation of a proposed corporate action. If the document were a proxy statement soliciting votes, it would be PSI. Since it is the Board's justification report required by law for the EGM, it functions as a key governance/management document. Given the context of corporate actions and board reports, MDA is the most appropriate general classification for a detailed, non-financial results-focused board report. *Self-Correction based on content:* The document is a statutory report justifying a share option plan and the disapplication of pre-emptive rights, which is a significant capital structure/governance matter presented to shareholders. It is not a standard earnings report or annual report. It is a formal legal/governance document detailing management's proposal. I will classify it as Governance Information (CGR) as it details the structure and justification for a major corporate action impacting shareholder rights, which falls under governance practices, or MDA. Given the focus on the proposal itself, MDA is slightly more fitting for a detailed report explaining a management decision/plan.
2025-04-22 English
2 -- Attendance Form (NL-ENG).pdf
AGM Information Classification · 98% confidence The document is explicitly titled "DEELNEMINGSFORMULIER VOOR HOUDERS VAN EFFECTEN GEWONE EN BUITENGEWONE ALGEMENE VERGADERINGEN" (ATTENDANCE FORM FOR SECURITY HOLDERS ORDINARY AND EXTRAORDINARY GENERAL MEETINGS). This form is used by security holders to register their intent to attend the upcoming Ordinary and Extraordinary General Meetings scheduled for May 22, 2025. This material is directly related to the logistics and requirements for attending the Annual General Meeting (AGM) and is a key component of the overall AGM process, fitting the definition of AGM Information (AGM-R). It is not the final voting results (DVA), the proxy solicitation materials (PSI), or the meeting presentation itself.
2025-04-22 Dutch
8 -- Special Board Report Authorised Capital (ENG).pdf
Share Issue/Capital Change Classification · 95% confidence The document is explicitly titled "SPECIAL REPORT OF THE BOARD OF DIRECTORS IN ACCORDANCE WITH ARTICLE 7:199 OF THE BELGIAN COMPANIES AND ASSOCIATIONS CODE". This report details a proposal to renew the board's power to increase the company's share capital under the authorised capital, which is a matter directly related to capital structure and shareholder rights, typically presented ahead of an Extraordinary General Meeting (EGM). Key indicators are: 1. Explicit mention of a proposal to be submitted to an "extraordinary general shareholders' meeting". 2. The content focuses entirely on the mechanics, history, and renewal of the 'authorised capital' and the ability to issue shares/securities. 3. This type of detailed report explaining a specific corporate action proposal to shareholders aligns best with documents related to shareholder meetings or capital changes. While it involves capital changes (suggesting CAP or SHA), the document's primary function is to provide the legally required report/justification for a proposed resolution to be voted on at a shareholder meeting, specifically concerning capital authorization. This structure is highly characteristic of materials prepared for a general meeting, often accompanying a Proxy Statement (PSI) or being a standalone report required for such a vote. Given the focus on the proposal for capital authorization to be voted on, it is most closely related to the context of a general meeting or a specific capital action. Comparing the options: - CAP (Capital/Financing Update): It is about capital, but it's a formal report justifying a resolution, not just an announcement of a financing event. - SHA (Share Issue/Capital Change): This is the *subject*, but the document is the *report* justifying the authorization for future changes. - PSI (Proxy Solicitation & Information Statement): This document serves the informational purpose required before a shareholder vote on a major corporate action, fitting the definition of providing information for a meeting. However, the document is a formal 'Special Report of the Board of Directors' required by Belgian law (Article 7:199) specifically concerning the renewal of capital powers. This is a highly specific corporate governance/capital structure document. Since there isn't a perfect fit for a 'Report on Proposed Capital Authorization for EGM', I must choose the closest category. Given the context of proposing changes to the Articles of Association regarding capital, and the detailed justification provided, it is a specific type of corporate governance/capital action document. Since it is a formal report detailing the structure and rules for capital changes, and it is being presented to shareholders for approval, it strongly relates to the process surrounding shareholder meetings and capital structure. If we consider the core action: proposing a change to the capital structure (Article 8 of AoA), it relates to 'CAP' (Capital/Financing Update) or 'SHA' (Share Issue/Capital Change). But because it is a formal report justifying the authorization for future capital changes presented to shareholders, it is often bundled with proxy materials (PSI) or treated as a specific capital action document. Given the depth and legal nature, and the fact that it is a report *about* capital authorization, 'CAP' seems the most appropriate fit among the provided choices for a document detailing the framework for future capital raising/issuance powers, even though it is presented at an EGM. Revisiting the definitions, this document is a formal report justifying the renewal of the board's power to issue shares. This is a fundamental aspect of capital management. I will classify it as 'CAP' (Capital/Financing Update) because the entire document revolves around the authorization framework for capital increases.
2025-04-22 English
4 -- Vote by Mail Form (NL-ENG).pdf
AGM Information Classification · 98% confidence The document is explicitly titled 'FORMULIER VOOR STEMMING PER BRIEF' (Vote By Mail Form) for 'GEWONE EN BUITENGEWONE ALGEMENE VERGADERINGEN' (Ordinary and Extraordinary General Meetings). It contains detailed instructions on how shareholders must submit their votes by mail for the meeting scheduled for May 22, 2025. The agenda items listed (e.g., approval of statutory and consolidated financial statements for the year ended December 31, 2024) are typical items discussed at an Annual General Meeting (AGM). This document is the mechanism for voting at the AGM, not the AGM presentation itself, nor the final voting results. Therefore, it is best classified as material related to the AGM, specifically the voting process, which aligns closely with the purpose of an AGM document, but since there is a specific code for AGM-related materials, AGM-R is the most appropriate fit, as it governs the meeting itself.
2025-04-22 Dutch
Annual Report 2024 ENG-vF.pdf
Annual Report Classification · 100% confidence The document is explicitly titled 'ANNUAL REPORT 2024' and contains a comprehensive table of contents covering business strategy, corporate governance, remuneration reports, and full financial statements (Income Statement, Balance Sheet, Cash Flows, etc.). It is a substantial document (over 700,000 characters) that provides a detailed account of the company's yearly performance, strategy, and financial position, fitting the definition of a 10-K/Annual Report. FY 2024
2025-04-22 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.